In the present study, to better understand the importance of LAG-3 in breast cancer and its interaction and correlation with other immune checkpoints, such as CTLA-4 and PD-1, we evaluated the prognostic significance of LAG-3 by gene-expression analysis in a cohort of 461 breast cancer patients. This evidence concerns the gene CTLA4 and breast cancer.